Item 8.01. Other Events

On January 23, 2009, Geron Corporation (the "Company") publicly disseminated a press release announcing that the U.S. Food and Drug Administration (FDA) has granted clearance of the Company's Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.

The foregoing description is qualified in its entirety by reference to the Company's Press Release dated January 23, 2009, a copy of which is attached hereto as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits

(c) Exhibits

99.1 Press release dated January 23, 2009.

---